Webdisclosure.com

SANOFI-AVENTIS (EPA:SAN)

31/01/2022 21:10

Sanofi: Disclosure of trading in own shares

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

26/01/2022 02:06

Sanofi: Disclosure of trading in own shares

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

14/01/2022 21:16

Sanofi: Disclosure of trading in own shares

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

21/12/2021 21:52

Sanofi: Information concerning the total number of voting rights and shares - NOVEMBER 2021

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

01/12/2021 20:46

Sanofi: Information concerning the total number of voting rights and shares - October 2021

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

18/11/2021 07:30

Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

09/11/2021 15:05

Sanofi completes acquisition of Kadmon

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

27/10/2021 20:57

Sanofi: Information concerning the total number of voting rights and shares - September 2021

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

20/10/2021 23:30

FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with moderate-to-severe asthma

Voir tous les communiqués de SANOFI-AVENTIS

SANOFI-AVENTIS (EPA:SAN)

01/10/2021 20:28

Sanofi: Information concerning the total number of voting rights and shares - August 2021

Voir tous les communiqués de SANOFI-AVENTIS

«
2
3
4
5
6
7
8
9
10